Adrenal atrophy medical therapy

Revision as of 04:48, 5 February 2022 by Maryam Hadipour (talk | contribs)
Jump to navigation Jump to search

Adrenal atrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenal atrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenal atrophy medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenal atrophy medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenal atrophy medical therapy

CDC on Adrenal atrophy medical therapy

Adrenal atrophy medical therapy in the news

Blogs on Adrenal atrophy medical therapy

Directions to Hospitals Treating Adrenal atrophy

Risk calculators and risk factors for Adrenal atrophy medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Treatment of adrenal atrophy is conservative. In case of adrenal crisis IV fluid and steroid are recommended.

Medical therapy

Adrenal atrophy is the irreversible damage to the adrenal tissue, due to direct trauma or the secondary causes. As a result, treatment of the adrenal atrophy is a conservative treatment. For adrenal crisis:

The cortisol deficiency is treated by supplementing with cortisol, prednisolone, prednisone, methylprednisolone, and dexamethasone. The mineralocorticoid insufficiency is also cured by the fludrocortisone. [1][2]

References

  1. Hahner S, Allolio B (April 2009). "Therapeutic management of adrenal insufficiency". Best Pract Res Clin Endocrinol Metab. 23 (2): 167–79. doi:10.1016/j.beem.2008.09.009. PMID 19500761.
  2. Barnett AH, Espiner EA, Donald RA (November 1982). "Patients presenting with Addison's disease need not be pigmented". Postgrad Med J. 58 (685): 690–2. doi:10.1136/pgmj.58.685.690. PMC 2426562. PMID 7170268.

Template:WH Template:WS